PAM
RDHL

Panagora Asset Management’s Redhill Biopharma RDHL Stock Holding History

Panagora Asset Management’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1
Closed -$7K – 2929
2021
Q1 		$7K Sell
1
-1
-50% -$8.39K ﹤0.01% 2507
2020
Q4 		$16K Hold
2
– – ﹤0.01% 2225
2020
Q3 		$21K Buy
+2
New +$16.4K ﹤0.01% 2194

Other funds holding RDHL

DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $127M AUM

Panagora Asset Management's RDHL Position: Q2 2021 in Review

Panagora Asset Management sold out of Redhill Biopharma (RDHL) in Q2 2021, closing a stake of 1 share — an estimated $7K sold.

Panagora Asset Management first reported a position in RDHL in Q3 2020 and held it in 3 quarters. The position peaked at $21K in Q3 2020. 48 funds tracked by Wall St. Rank hold RDHL as of Q2 2021.

  • Panagora Asset Management reported no remaining Redhill Biopharma position as of Q2 2021 after selling out during the quarter.
  • Panagora Asset Management sold 1 Redhill Biopharma share in Q2 2021, an estimated $7K.
  • Panagora Asset Management first reported a position in Redhill Biopharma in Q3 2020 and held it in 3 quarters.
  • Panagora Asset Management's Redhill Biopharma position peaked at $21K in Q3 2020.
  • 48 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2021.

Based on Panagora Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.